- Oliver S. P. Davis
(Evolution and Environment, UCL Genetics Institute, University College London
King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry)
- Gavin Band
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- Matti Pirinen
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- Claire M. A. Haworth
(King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry
University of Warwick)
- Emma L. Meaburn
(Birkbeck, University of London)
- Yulia Kovas
(Goldsmiths, University of London)
- Nicole Harlaar
(University of Colorado Boulder)
- Sophia J. Docherty
(King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry)
- Ken B. Hanscombe
(King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry)
- Maciej Trzaskowski
(King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry)
- Charles J. C. Curtis
(King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry)
- Amy Strange
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- Colin Freeman
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- Céline Bellenguez
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- Zhan Su
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- Richard Pearson
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- Damjan Vukcevic
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- Cordelia Langford
(Wellcome Trust Sanger Institute)
- Panos Deloukas
(Wellcome Trust Sanger Institute)
- Sarah Hunt
(Wellcome Trust Sanger Institute)
- Emma Gray
(Wellcome Trust Sanger Institute)
- Serge Dronov
(Wellcome Trust Sanger Institute)
- Simon C. Potter
(Wellcome Trust Sanger Institute)
- Avazeh Tashakkori-Ghanbaria
(Wellcome Trust Sanger Institute)
- Sarah Edkins
(Wellcome Trust Sanger Institute)
- Suzannah J. Bumpstead
(Wellcome Trust Sanger Institute)
- Jenefer M. Blackwell
(Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia
Cambridge Institute for Medical Research, University of Cambridge School of Clinical Medicine)
- Elvira Bramon
(UCL Institute of Cognitive Neuroscience, University College London
UCL Mental Health Sciences Unit, University College London)
- Matthew A. Brown
(University of Queensland Diamantia Institute, Translational Research Institute, Princess Alexandra Hospital, University of Queensland)
- Juan P. Casas
(London School of Hygiene and Tropical Medicine
University College London)
- Aiden Corvin
(Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin)
- Audrey Duncanson
(Molecular and Physiological Sciences, The Wellcome Trust)
- Janusz A. Z. Jankowski
(Centre for Digestive Diseases, Blizard Institute, Queen Mary University of London
Wolfson College
Peninsula School of Medicine and Dentistry, Associate Deans Office, John Bull Building)
- Hugh S. Markus
(Clinical Neurosciences, Saint George's University of London)
- Christopher G. Mathew
(King’s College London, King’s Health Partners Guy’s Hospital)
- Colin N. A. Palmer
(Biomedical Research Centre, Ninewells Hospital and Medical School)
- Anna Rautanen
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- Stephen J. Sawcer
(University of Cambridge, Addenbrooke’s Hospital)
- Richard C. Trembath
(King’s College London, King’s Health Partners Guy’s Hospital)
- Ananth C. Viswanathan
(NIHR Biomedical Research Centre at Moorfields Eye Hospital NHSFT and UCL Institute of Ophthalmology)
- Nicholas W. Wood
(Institute of Neurology, University College London)
- Ines Barroso
(Wellcome Trust Sanger Institute)
- Leena Peltonen
(Wellcome Trust Sanger Institute)
- Philip S. Dale
(University of New Mexico)
- Stephen A. Petrill
(Institute for Population Research, The Ohio State University)
- Leonard S. Schalkwyk
(King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry)
- Ian W. Craig
(King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry)
- Cathryn M. Lewis
(King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry)
- Thomas S. Price
(Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine)
- Peter Donnelly
(Wellcome Trust Centre for Human Genetics, University of Oxford
University of Oxford)
- Robert Plomin
(King’s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry)
- Chris C. A. Spencer
(Wellcome Trust Centre for Human Genetics, University of Oxford)